Nobumasa Awai

Title: Nobumasa Awai: Innovator in Sulfonamide Compounds

Introduction

Nobumasa Awai is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sulfonamide compounds. With a total of five patents to his name, Awai's work has the potential to impact various therapeutic areas.

Latest Patents

Awai's latest patents focus on sulfonamide compounds that exhibit TRPM8 antagonistic activity. These compounds are characterized by a specific chemical structure, where Ring A is a bicyclic aromatic heterocycle that can be formed by the condensation of pyridine with either benzene or a monocyclic aromatic heterocycle. The sulfonamide compounds are designed to bind to a sulfonylamino moiety adjacent to a nitrogen atom in the pyridine ring. This innovative approach may lead to new therapeutic options in treating conditions related to TRPM8 activity.

Career Highlights

Throughout his career, Nobumasa Awai has worked with notable companies in the pharmaceutical industry. He has been associated with Mitsubishi Tanabe Pharma Corporation and Shanghai Pharmaceuticals Holding Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Awai has collaborated with several professionals in his field, including Hidenori Akatsuka and Takayuki Kawaguchi. These collaborations have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Nobumasa Awai is a distinguished inventor whose work in sulfonamide compounds showcases his innovative spirit and dedication to advancing pharmaceutical science. His contributions are expected to have a lasting impact on the industry.